SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-009298
Filing Date
2021-05-06
Accepted
2021-05-06 16:08:27
Documents
16
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K auph-20210506.htm   iXBRL 8-K 38819
2 EX-99.1 exhibit991_q12021pressrele.htm EX-99.1 97642
8 aurinalogo1.jpg GRAPHIC 11010
  Complete submission text file 0001628280-21-009298.txt   302894

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210506.xsd EX-101.SCH 2451
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20210506_cal.xml EX-101.CAL 732
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20210506_def.xml EX-101.DEF 1669
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210506_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210506_pre.xml EX-101.PRE 12668
9 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210506_htm.xml XML 11099
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36421 | Film No.: 21897776
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences